Vanguard Group Inc. lessened its stake in shares of Teleflex Incorporated (NYSE:TFX – Free Report) by 0.8% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,545,520 shares of the medical technology company’s stock after selling 43,876 shares during the period. Vanguard Group Inc. owned about 11.94% of Teleflex worth $986,992,000 as of its most recent filing with the SEC.
Several other large investors have also recently bought and sold shares of TFX. Vontobel Holding Ltd. raised its stake in shares of Teleflex by 21.9% during the 4th quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company’s stock worth $248,000 after purchasing an additional 250 shares in the last quarter. JPMorgan Chase & Co. raised its position in Teleflex by 14.3% during the third quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock worth $38,374,000 after acquiring an additional 19,466 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. raised its position in Teleflex by 5.2% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company’s stock worth $19,263,000 after acquiring an additional 5,322 shares in the last quarter. Lecap Asset Management Ltd. acquired a new stake in Teleflex in the fourth quarter valued at $729,000. Finally, Mirae Asset Global Investments Co. Ltd. grew its position in shares of Teleflex by 35.1% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company’s stock valued at $1,053,000 after acquiring an additional 1,527 shares during the period. 95.62% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several equities research analysts recently issued reports on the stock. Piper Sandler reiterated a “neutral” rating and issued a $140.00 target price (down from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Bank of America cut Teleflex from a “neutral” rating to an “underperform” rating and cut their price objective for the company from $235.00 to $140.00 in a research report on Tuesday, March 4th. Royal Bank of Canada lowered Teleflex from an “outperform” rating to a “sector perform” rating and decreased their target price for the stock from $220.00 to $155.00 in a report on Friday, February 28th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a report on Wednesday, March 12th. Finally, Citizens Jmp downgraded shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $182.63.
Teleflex Trading Down 1.2 %
NYSE:TFX opened at $137.76 on Friday. Teleflex Incorporated has a 52 week low of $128.55 and a 52 week high of $249.91. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The firm’s fifty day moving average is $159.20 and its 200-day moving average is $190.75. The firm has a market cap of $6.39 billion, a P/E ratio of 27.39, a P/E/G ratio of 1.73 and a beta of 1.21.
Teleflex (NYSE:TFX – Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. The firm had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Equities analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.
Teleflex Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were paid a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.99%. The ex-dividend date was Friday, March 7th. Teleflex’s dividend payout ratio (DPR) is presently 95.77%.
Teleflex Company Profile
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Further Reading
- Five stocks we like better than Teleflex
- How to Use the MarketBeat Excel Dividend Calculator
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- What is Insider Trading? What You Can Learn from Insider Trading
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- Want to Profit on the Downtrend? Downtrends, Explained.
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.